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Abstract
The widespread distribution of the tumor suppressor PTEN in the nervous system suggests a role in a broad range of brain
functions. PTEN negatively regulates the signaling pathways initiated by protein kinase B (Akt) thereby regulating signals for
growth, proliferation and cell survival. Pten deletion in the mouse brain has revealed its role in controlling cell size and
number. In this study, we used Cre-loxP technology to specifically inactivate Pten in dopamine (DA) neurons (Pten KO mice).
The resulting mutant mice showed neuronal hypertrophy, and an increased number of dopaminergic neurons and fibers in
the ventral mesencephalon. Interestingly, quantitative microdialysis studies in Pten KO mice revealed no alterations in basal
DA extracellular levels or evoked DA release in the dorsal striatum, despite a significant increase in total DA tissue levels.
Striatal dopamine receptor D1 (DRD1) and prodynorphin (PDyn) mRNA levels were significantly elevated in KO animals,
suggesting an enhancement in neuronal activity associated with the striatonigral projection pathway, while dopamine
receptor D2 (DRD2) and preproenkephalin (PPE) mRNA levels remained unchanged. In addition, PTEN inactivation protected
DA neurons and significantly enhanced DA-dependent behavioral functions in KO mice after a progressive 6OHDA lesion.
These results provide further evidence about the role of PTEN in the brain and suggest that manipulation of the PTEN/Akt
signaling pathway during development may alter the basal state of dopaminergic neurotransmission and could provide a
therapeutic strategy for the treatment of Parkinson’s disease, and other neurodegenerative disorders.
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Introduction
Pten (for ‘phosphatase and tensin homologue deleted on chromo-
some ten’) is a tumor suppressor gene mutated in many human
cancers, including glioblastomas, a highly malignant glial tumor in
the CNS [1]. Individuals with germline Pten mutations are prone to
tumors and may display brain disorders, including macrocephaly,
seizures and mental retardation [2].
The tumorsuppressive property of PTENis dependent onits lipid
phosphatase activity, which restrains the activation of the Akt (also
called protein kinase B) signaling pathway. Upon activation, Akt
phosphorylates a diverse spectrum of substrates known to regulate
cellular functions related to cell cycle progression, cell growth and
proliferation, cell death/survival and cell differentiation [3].
PTEN is widely distributed in the brain and is preferentially
expressed in neurons, where it localizes to both the nucleus and
cytoplasm [4–7]. The role of PTEN in the brain has been largely
focused on the pathogenesis of glioblastoma; however, progress
has recently been made in understanding the broader role of
PTEN in neural circuits. A number of in vitro studies indicates a
role for PTEN signaling in neuronal size, dendritic and axonal
branching and neuronal polarization [8,9]. To analyze the role of
PTEN in vivo and in specific neuronal populations mutant mice
have been generated to induce the loss of the phosphatase in a
tissue-specific manner by using the Cre-LoxP technology. Condi-
tional loss of Pten in the brain can have differing consequences
depending on the cell type or state of differentiation. For example,
the use of a Nestin promoter to induce Pten deletion in neural stem
cells and glial progenitors resulted in neonatal death, as mice
showed enlarged and histoarchitecturally abnormal brains [10].
Pten deletion in discrete mature neuronal populations in the
cerebral cortex and hippocampus resulted in macrocephaly due to
neuronal hypertrophy. In addition abnormalities in axonal growth
and synapse number resulted in abnormal social behavior and
inappropriate responses to sensory stimuli [11].
Recent studies have emphasized the association of PTEN with
different parameters of the dopaminergic system in the ventral
midbrain. For example, the continuous activation of the down-
stream PTEN pathway, Akt, in mesostriatal adult dopamine
neurons by unilateral adenoviral injections in the substantia nigra
compacta confers almost complete protection against apoptotic cell
death in a dopamine toxin specific model [12]. In addition, a recent
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may also regulate functions intrinsic to dopamine neurons, such as
cellular and behavioral responses to stressful stimuli [13]. Besides
the inhibitory control on the activation of the Akt pathway, PTEN
interacts with molecular substrates directly involved in neurotrans-
mission such as glutamate and serotonin receptors [13,14].
Normally the activity of mesolimbic dopamine cells is under the
tonic inhibitory control of the phosphorylated serotonin receptor 2c
(5-HT2c). PTEN deletion in DA cells favors the phospholylated
state of the 5-HT2c receptor, inhibits dopaminergic transmission
and abolishes the rewarding effects of nicotine and tetrahydrocan-
nabinol [13]. These studies suggest PTEN function in dopamine
neurons is not limited to the classical deregulation of the Akt
pathway, and PTEN may also have an effect on distinct functions
related to dopamine-mediated cognition. To further examine the
correlation between PTEN and the dopaminergic system, we
developed a mouse transgenic model to inactivate PTEN signaling
specifically in DA neurons. We now report that PTEN ablation
during development results in profound morphological, molecular
and neurochemical changes inDA neuron maturation that translate
into permanent adaptations of the dopaminergic system, including
significant changes in postsynaptic brain areas. Additionally, and in
agreement with previous studies [12], we show that PTEN deletion
in dopamine cells provides significant protection against neurotoxic
insults. Such adaptations will be documented in detail in this report.
Future studies will be aimed at correlating the molecular





loxP mice were obtained from Jackson laboratories [14]. Mice
were obtained in a background comprised of a mix of c57bl/6,
129S4/SvJae. All animals used in this study were analyzed
between 3–4 months of age. Animal protocols used in this study
were approved by the Animal Care Committee at the National
Institutes of Health. For the conditional inactivation of Pten in
dopaminergic neurons of the ventral midbrain, we developed a
dopamine transporter (DAT) promoter-driven Cre transgenic
mouse line Slc6a3
Cre [15]. Cre recombinase binds to loxP target
sequences and either deletes or inverts the intervening DNA
depending on the individual orientation of the loxP sites [16]. In
our model, Cre recombinase expression is driven by the DAT
promoter and mediates deletion of exon 5 of the pten gene
approximately at embryonic day 15 [15]. DAT is a molecular
substrate specific to dopamine neurons and is highly expressed in
dopamine neurons of the ventral midbrain, while lesser expression
levels are present in the olfactory bulb and hypothalamic areas. To
minimize interference with DAT function by preservation of both
DAT alleles, Cre recombinase expression was driven from the 39-
untranslated region (39UTR) of the endogenous DAT gene by
means of an internal ribosomal entry sequence (IRES). The Pten
loxP
and Slc6a3
Cre lines were mixed to obtain regional knockout
(Pten
loxP/loxP/Cre/wt) and control mice (Pten
wt/wt/Cre/wt). Animals
were genotyped using Pten and Slac6a3-Cre primers described
elsewhere [14,15].
To confirm if Pten deletion was specific to DAT expressing
regions, primers specific to the recombination (delta5) were
developed. Genomic DNAs were prepared from the olfactory
bulb, motor cortex, striatum and SN/VTA. For ventral midbrain
dissections, coronal cuts were made at the anterior and posterior
boundaries of the mammillary nucleus. Dissection of the ventral
midbrain region containing the SN/VTA was facilitated by
removing the mammillary nucleus on the ventral surface and
overlying cortex on the dorsal surface. A block containing the SN/
VTA was then dissected. To further ensure specificity of Cre
mediated recombination lung, heart, kidney and liver tissue was
dissected and DNA extracted for PCR analysis.
Immunohistochemistry
Adult mice were deeply anesthetized with an intraperitoneal
(i.p.) injection of chloral hydrate (30 mg/kg) and then perfused
transcardially with saline solution followed by 4% paraformalde-
hyde (PFA). Brains were quickly removed from skull and post-fixed
in 4% PFA for 4 hrs. After fixation, brains were rinsed in 0.1 M
phosphate buffer (PB) and cryoprotected in 18% sucrose solution,
overnight at 4uC.
Striatum and midbrain regions were cut in coronal sections at
40 um in four series using a Leica CM3050S cryostat (Leica
Microsystems, Bannockburn, IL). Sections were processed for
Tyrosine Hydroxylase (TH) immunohistochemistry or for Pten or
phosho-AKT immunofluoresce. For TH immunohistochemical
studies, sections were rinsed with PB 3610 min and then
permeabilized and blocked with 0.25% Triton-X-100 and 4%
bovine serum albumin (BSA) in 0.1 M PB. Sections were
incubated overnight at 4uC with a rabbit polyclonal antibody
against TH (1:1000, Chemicon, Temecula, CA). Sections were
then rinsed 3610 min in PB, and incubated for 1 hr with a
biotinylated anti-rabbit antibody (1:200, Vector Labs, Burlingame,
CA). Sections were rinsed with PB 3610 min and incubated with
avidin-biotinylated horseradish peroxidase for 2 h. Sections were
rinsed and the peroxidase reaction was developed with 0.05% 3,3-
diaminobenzidine-4 HCl (DAB) and 0.003% hydrogen peroxide
(H2O2). Sections were mounted on coated slides, coversliped and
dried before analysis.
For immunofluorescence histochemistry, sections were rinsed in
PB 3610 min, and then incubated with 0.25% Triton-X-100 and
4% BSA in 0.1 M PB. Sections were incubated with a mouse
monoclonal anti PTEN (Cell Signaling, Danvers, MA) or with anti
p-AKT rabbit monoclonal antibody (1:100, Cell Signaling,
Danvers, MA) overnight at 4uC. Sections were rinsed with PB
3610 min and incubated for 2 hrs at room temperature with one
of the following secondary fluorescent antibodies: anti mouse or
anti rabbit (Invitrogen, Carlsbad, CA), rinsed with PB 3610 min,
mounted on coated slides and coversliped. Sections were analyzed
in a Leica DMLA microscope (Leica Microsystems, Bannockburn,
IL) with fluorescent light.
Stereologic Analyses
Unbiased stereological counts of TH-positive (TH+) neurons
within the substantia nigra pars compacta (SNc) and ventral
tegmental area (VTA) as well as fiber length in the substantia nigra
pars reticulata (SNr) were performed using stereological principles
[17] and analyzed with StereoInvestigator software (Microbright-
field, Williston, VT). The optical fractionator probe [18] was used
to generate an estimate of neuronal TH+ number and area,
nucleator probe [19] to estimate the size of TH+ neurons in SNc
and VTA and space balls probe [20] to obtain an estimate of the
total length of fibers in the SNr. SNc, VTA and SNr were outlined
under a low magnification objective (5x) following landmarks from
the Franklin and Paxinos mouse atlas [21] and all the stereologic
analysis were performed under the 40x objective of a Leica
DM5000B microscope (Leica Microsystems, Bannockburn, IL).
The total number of TH+ neurons, neuronal size and fiber
density, was estimated for adult naı ¨ve control and Pten KO mice.
For each tissue section analyzed, section thickness was assessed in
each sampling site and guard zones of 2.5 mm were used at the top
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was performed and generated with the following stereologic
parameters: grid size: 131 mm, counting frame: 123 mm and
dissector height of 25 mm. For space balls a 20 mm radius was used
to intersect fibers that crossed the circle. The criterion for a TH+
fiber was a stained and in focus fiber at the crossing point in the
circle. Our criterion for counting and measuring the area of an
individual TH+ neuron was the presence of its nucleus either
within the counting frame, or touching the right or top frame lines
(green), but not touching the left or bottom lines (red). The area of
TH+ neurons in the SNc and VTA was estimated using the
nucleator probe. Every time a neuron was counted with the optical
fractionator probe, a set of four rays are extended from the middle
of the cell and radiate with a random orientation in four
orthogonal directions towards the edge of the neuron. The point
at which each ray intersected the boundary of the neuron are used
to define the area. Coefficients of error were calculated and values
,0.10 were accepted.
Stereologic estimations were also performed with the same
parameters in the SNc of control and Pten KO mice thirty days
after receiving a unilateral 6OHDA lesion in the striatum. Results
were presented as a percentage of surviving neurons on the
contralateral side.
Optical Density
To determine fiber density in the striatum, the mean optical
density (O.D.) was measured in TH positive stained sections from
naı ¨ve and 6OHDA-lesioned mice (thirty days after 6-OHDA
unilateral lesion) in control and Pten KO mice. O.D. is a sensitive
and reliable tool to measure levels of fiber innervation and to
detect changes by experimental manipulations [22]. Images were
captured with a Hitachi CCD HV-C20A camera and transformed
to grey scale images of 8 bits. The O.D. quantification was
perform using ImageJ software [23]. The O.D. measures were
determined in each mouse at three coronal levels corresponding to
the frontal striatum +1.5 mm, medial striatum +0.14 mm. and
caudal striatum 20.50 mm, relative to bregma [21]. Nonspecific
background was determined by readings made from the anterior
commissure or corpus callosum. For naı ¨ve animals, the O.D value
corresponds to the mean of both striatae minus the respective
background level. For 6OHDA-treated animals, O.D. values were
measured on the denervated and non denervated striatum in
control and KO mice and the O.D. minus the background was
expressed as a percentage relative to the contralateral side. In
addition, striatal total area was determined with the same software
and results expressed as square pixels.
Behavioral Test: Locomotor activity induced by exposure
to a novel environment
All mice used were adult and kept on a 12:12 light – dark cycle
(lights on 06:00 am) with food and water ad libitum. Behavioral tests
were performed between 10:00–14:00 hrs. Locomotor activity
assessed in the open field, is considered a well organized behavior
in rodents determined by several factors, including anxiety, arousal,
risk assessment, and exploration, and is an established tool for
behavioral phenotyping in mice [24]. Control and Pten KO mice
were brought to the testing room 30 minutes before the procedure
began for acclimation. After this period, each mouse was gently
placed inside a clean Plexiglas chamber (42642630 cm; Accuscan
Instruments, Columbus, OH) for 30 minutes to assess locomotor
activity in a new environment. Locomotor activity was measured in
each cage by 16 horizontal and 16 vertical sensors (infrared beams)
spaced 2.5 cm apart. Vertical sensors were located 7 cm above the
floor chamber. Data was stored every 5 min and presented as
cumulative values after 30 minutes.
Real time PCR
Striatal tissue was dissected and immediately processed for RNA
isolation and DNAse I treatment using the RNAqueous-Micro
Ambion kit (Applied Biosystems- Ambion, Austin, TX), following
the manufacturers instructions. For cDNA synthesis total RNA
was mixed following the manufacturers instructions for the
Superscript III reverse transcriptase kit (Invitrogen, Carlsbad,
CA). Real-time polymerase chain reaction was performed as
duplicate determinations with specific Taqman probes from the
mouse Probe Library (Exiqon A/S, Vedbaek, Denmark) designed
for primers to mouse DRD1 (F: 59- gag cgt agt ctc cca gat cg-39
and B: 59- tgg tca atc tca gtc act ttt ca- 39), DRD2 (F: 59-ctc ttt gga
ctc aac aac aca ga- 39 and B: 59 -aag ggc acg tag aac gag ac- 39),
preproenkephalin (F: 59 -aag ggc acg tag aac gag ac- 39 and B: 59 -
aag ggc acg tag aac gag ac- 39), prodynorphin (F: 59-aag ggc acg
tag aac gag ac- 39 and B: 59-cgc cat tct gac tca ctt gtt- 39), and
BDNF (F: 59 -gca tct gtt ggg gag aca ag- 39 and B: 59-tgg tca tca ctc
ttc tca cct g- 39). Hydroxymethylbilane synthase (Hmbs, F: 59-tcc
ctg aag gat gtg cct ac-39 and B: 59- aca agg gtt ttc ccg ttt g- 39) and
aminolevulinate synthase (ALAS, F:59- cca tca att acc caa cag tgc-
39 and B: 59-gtg acc agc agc ttc tcc a-39) were used as housekeeping
genes to normalize quantification data. The reproducibility of
results was determined by inspection of duplicate samples. After an
initial incubation step for 10 min at 95uC, qRT-PCR was carried
out using 40 cycles (95uC for 15 seconds, 60uC for 60 seconds).
The standard curve method was used to compare mRNA
expression levels between KO and control animals. Normalization
to both endogenous control genes led to similar results.
In Vivo Microdialysis
Pten deficient mice and controls were anesthetized and
implanted unilaterally with a microdialysis guide cannula
(CMA/11, CMA microdialysis) in the dorsal striatum (AP: +0.4,
L: -2.1, V: -2.2 mm from bregma) using standard stereotaxic
techniques, and were allowed to recover for 5 days before the
microdialysis experiments [25]. Fifteen hours before the start of
experiments, a microdialysis probe (CMA/11, 2 mm membrane
length, CMA microdialysis, North Chelmsford, MA) was con-
nected to the dialysis system and flushed with artificial cerebro-
spinal fluid (aCSF: 145 mM NaCl, 2.8 mM KCl, 1.2 mM CaCl2,
1.2 mM MgCl2, 0.25 mM ascorbic acid, and 5.4 mM D-glucose,
pH 7.2 adjusted with NaOH 0.5 M). The mouse was gently
restrained and the probe was slowly inserted into the guide
cannula. The dialysis system consisted of FEP tubing (CMA
microdialysis) that connected the probe to a 1 ml gastight syringe
(Hamilton Co., Reno, NV) mounted on a microdialysis pump
(CMA/102) through a quartz-lined, low-resistance swivel (375/D/
22QM, Instech, Plymouth Meeting, PA). After probe insertion, the
mouse was placed in the dialysis chamber with food and water
freely available, and the probe perfused overnight with aCSF at a
flow rate of 0.3 ml/min. The next morning, the perfusion syringes
were loaded with fresh aCSF and probes were allowed to
equilibrate for an additional 1 h at a flow rate of 0.6 ml/min
before the start of experiments.
For no net flux experiments, five different concentrations of DA
(0, 5, 10, 20, and 40 nM) in aCSF were perfused in random order
through the dialysis probe. Each DA concentration was perfused
for 30 min, and then 2|10 min samples were collected.
Following completion of the no net flux experiments, normal
aCSF was again perfused through the probe for 30 min, allowing
for a period of equilibration. Consecutive 15 min samples were
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followed by changing the perfusion buffer to aCSF containing
60 mM KCl (NaCl concentration was reduced accordingly to
maintain osmolarity) and four samples were obtained. The
perfusion buffer was switched back to normal aCSF and three
additional samples were collected. After the experiments, mice
were killed by pentobarbital overdose and their brains were
removed. The midbrain and left dorsal striatum were dissected
out, frozen on dry ice and stored at 280 for tissue DA content
determination. The right forebrain was frozen on dry ice, and
20 mm sections were obtained on a cryostat for the histological
verification of probe location. No net flux data were analyzed as
described [25]. The net flux of DA through the probe (DAin–
DAout) was calculated and plotted against the concentration of
DA perfused (DAin). The following parameters were calculated
from the resulting linear function. The y axis intercept,
corresponding to zero DA perfused through the probe is the
dialysate DA concentration in a conventional microdialysis
experiment. The x axis intercept corresponds to the point of
equilibrium where there is no net flux of DA through the probe
and provides an unbiased estimate of extracellular DA concen-
tration. The slope of the regression line corresponds to the
extraction fraction (Ed) which has been shown to be an indirect
measure of DA uptake [25,26]. The resulting regression lines were
compared by Fisher’s test using GraphPad Prism software. In the
conventional microdialysis experiments investigating the effects of
60 mM KCl, the average of the three baseline samples was
calculated, and all the DA concentrations were expressed as % of
that baseline. Differences between control and Pten KO animals in
the appropriate variables were assessed by comparing both groups
using a Student’s t-test.
DA was determined by HPLC coupled to electrochemical
detection. The chromatographic system consisted of a CMA/200
refrigerated microinjector (CMA microdialysis, North Chelms-
ford, MA), a BAS PM-80 pump (BAS, West Lafayette, IN) and a
BAS LC-4C amperometric detector. The mobile phase (0.15 M
sodium phosphate, 2.24 mM sodium octanesulfonic acid,
0.94 mM EDTA, adjusted to pH 5.0 and containing 11%
methanol (vol/vol) was filtered through a 0.22-mm nylon filter,
degassed by a BAS online degasser, and pumped through the
system at a flow rate of 0.6 ml/min. DA was separated in a BAS
C18 column (100 mm62.0 mm63 mm) and detected on a glassy
carbon working electrode at an oxidation potential of +700 mV
vs. Ag/AgCl. Dialysate DA levels were quantified by external
standard curve calibration, using peak heights for quantification.
All the reagents used for the mobile phase were analytical grade.
Under these conditions, retention time for DA was 3 min, and
the limit of detection was 0.25 nM.
Tissue Levels of DA and metabolites
The midbrain and the left dorsal striatum were dissected after
the microdialysis experiments and stored at 280C for the
determination of monoamine content. Tissue samples were
homogenized by ultrasonication in 20 volumes of ice cold 0.05N
HClO4 containing 0.5 mM of DHBA as the internal standard.
Homogenates were centrifuged at 22000 g for 10 min at 4C.
Aliquots from the supernatant were analyzed for monoamine
content by HPLC coupled to electrochemical detection. The
chromatographic system was similar to the one described for
microdialysis experiments except for the column (10061m m
C18,5 um particle size, BAS) and the mobile phase (35.2 mM
sodium phosphate, 26.4 mM citric acid, 1.66 mM sodium
octanesulfonic acid and 0.1 mM EDTA adjusted to pH 4.2;
containing 6% methanol and 0.4% tetrahydrofurane, vol/vol).
The concentrations of monoamines were calculated against an
external standard curve, normalized by the internal standard and
corrected by the protein concentration in the homogenate.
6-Hydroxydopamine (6OHDA) Lesions
Mice were anesthetized with Avertin, and placed in a
stereotaxic frame. 6OHDA (5.0 mg/ml in 0.9% NaCl/0.02%
ascorbate) was injected using a microliter syringe at a rate of
0.5 ml/min for a total dose of 15.0 mg/3 ml. Injection was
performed into the striatum at coordinates AP: +0.09 cm; ML:
60.22 cm; DV: 20.25 cm relative to bregma. After 2 min, the
needle was withdrawn slowly. For amphetamine-induced rotation,
mice were injected with (+) methamphetamine HCl (2.5 mg/kg
i.p. injection) and placed in a rotometer (Accuscan, Columbus,
OH) for 120 min. Baseline amphetamine rotation tests were
performed 7 days before 6OHDA lesions and the results used to
assign the side of the subsequent 6OHDA lesion. Mice exhibiting
net clockwise turns were lesioned in the left striatum, while mice
exhibiting net counter-clockwise turns were lesioned in the right
striatum. Following the 6OHDA lesion, amphetamine-induced
rotational behavior was tested 14 and 28 days after lesion. The
number of clockwise and counter-clockwise turns was counted and
expressed as the number of net rotations per 120 minutes to the
lesioned (ipsilateral) hemisphere.
Statistical analyses
Unless otherwise stated, statistical analyses between control and
Pten KO animals were performed by using a Student’s t test with
values of *p,0.05 considered significant.
Results
Pten deletion is specific for cells expressing the
dopamine transporter (DAT)
To establish a mouse model carrying Pten deletion in
cells expressing DAT, we crossed Pten loxP mice with a
Slc6a3
Cre transgenic line. Of the offspring generated, we used
Pten
loxP/loxP/Cre/wt as knockouts (KO) and Pten
wt/wt/Cre/wt as
experimental controls. Pten KO mice were born at the expected
Mendelian ratio and were visibly indistinguishable from control
mice.
To confirm Cre-mediated recombination in Pten
loxP/loxP/Cre/wt
mice we used PCR and immunological strategies. As shown in
figure 1A, Pten exon5 deletion was specific to the SNc, VTA and
olfactory bulb in adult animals (delta5 band), with no detectable
leakage in other brain areas [15]. In addition, the extent of Pten
inactivation in KO mice was examined by immunocytochemistry
using antibodies against TH, PTEN and phospho-AKT. In KO
animals the loss of PTEN immunoreactivity in the ventral
mesencephalon was associated with increased TH and phospho-
AKT staining (Figure 1B).
As PTEN is a tumor suppressor gene and deregulation of this
pathway has been associated with the formation of multiple tumor
types, the animals used for morphological evaluations in this study
were examined for the existence of brain tumors. Sections through
the entire brain did not show evidence of neoplastic transforma-
tion in any of the brains analyzed (data not shown).
Pten deletion leads to neuronal hypertrophy and
increased number of TH positive neurons and dendrites
in the ventral midbrain
DA midbrain neurons are first generated near the midbrain-
hindbrain junction and migrate radially to their final position in
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limiting enzyme in the biosynthetic pathway of cathecholamines,
can be first detected in the mouse at embryonic day (E) 11.5,
suggesting initiation of DA differentiation [27]. In contrast, DAT
gene transcripts are not detected in the mouse ventral mesen-
cephalon until DA axons reach the target at about E15, suggesting
that during ontogeny, DA synthesis, and high-affinity uptake
develop asynchronously and in a non-correlated fashion [27]. In
DAT-Cre conditional transgenic mice, Cre recombinase activity is
induced shortly after DAT induction. In a previous report we first
detected DAT-Cre mediated beta galactosidase expression in a
conditional Rosa26LacZ reporter mice at embryonic day 17 [15],
suggesting excision of Pten exon5 at around this developmental
point. Stereological cell counts of TH positive profiles in the
substantia nigra and VTA were significantly elevated already at
postnatal day two (data not presented), indicating an early
expression of anatomical changes mediated by Pten ablation.
A common phenotype associated with the loss of PTEN in
neuronal populations is an enlargement of neuronal soma size,
increased cell proliferation, inhibition of apoptosis, and the
expression of thickened axonal and dendritic processes. We
performed detailed morphological analyses of brain structures
affected by the mutation in adult animals. PTEN ablation in DA
neurons (n=4) induced a significant increase in SNc and VTA
total volume (Fig. 2A and B; Fig. 3A) as compared to controls
(n=4). At a cellular level, this increased regional volume was
mainly attributed to a significant increase in the number of
neurons (Fig. 3B), as well as an increase in neuronal soma size
(Fig. 2A and 2B insets and 3C). Fiber density measurements also
revealed a significant increase in the number of dendritic processes
in the substantia nigra pars reticulata (SNr, Fig. 3D). In many
cases, dendritic processes were so close together and thickened in
the SNr that at low magnification may appear as cell bodies.
Interestingly, changes in neuronal size and number were not
accompanied by significant differences in striatal TH staining
intensity (Fig. 4A and 4C). Area measurements suggest a modest
but significant enlargement of the caudal striatum in KO animals
as compared to controls (Fig. 4B).
Figure 1. Cre recombinase deletes Pten exon 5 in neurons expressing the dopamine transporter. (A) PCR screen for Cre-mediated Pten
exon5 deletion. Genomic DNAs were prepared from the indicated brain tissues from a Pten
loxP/loxP/Cre/wt adult mouse. PCR analysis show Pten deletion
(delta5) is specific to the olfactory bulb and SN/VTA. Pten deletion could not be detected in other brain areas analyzed. (B) Immunofluorescent
staining shows TH and PTEN staining in the ventral mesencephalon of control and Pten KO animals. In the mutant animals, loss of PTEN activity is
associated with increased TH and membrane phospho-AKT staining. Sections correspond to Bregma -2.95 mm with reference to Franklin and Paxinos
(1997). Scale bar, 250 mm.
doi:10.1371/journal.pone.0007027.g001
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markers in the striatum
Over 90% of neurons of the striatum are medium spiny
projecting neurons. Distinct subpopulations of medium spiny
neurons can be recognized based on their projections and
expression of variousmarkers. Direct and indirect striatal projection
neurons selectively express the DRD1 and DRD2 dopamine
receptor subtypes respectively [29]. Messenger RNAs encoding
DRD1 are selectively localized in striatal neurons projecting to the
substantia nigra (direct pathway) and co-localize with dynorphin.
Conversely, mRNAs encoding DRD2 are selectively localized in
neurons projecting to the lateral globus pallidus (indirect pathway)
and colocalize with enkephalin. Real time quantitative PCR
analyses were performed to define if Pten ablation altered the
markers of the direct and indirect striatal pathways. Striatal mRNA
levels for PPE, PDyn, and DRD1 and DRD2 receptors revealed a
Figure 2. Pten deletion alters DA neurons in the ventral midbrain. Sections processed for TH immunostaining show a significant increase in
the number of TH immunopositive profiles in the substantia nigra compacta (SNc) and ventral tegmental area (VTA) of adult Pten KO animals when
compared to controls (A and B). The total area covered by TH positive staining was significantly increased in Pten KO animals when compared to
controls. Increase in the size of the mesolimbic and nigrostriatal projecting structures are due not only to an increase in the number of DA neurons,
but also to an increase in neuronal size and in dendritic outgrowth (see inserts in A and B). Sections correspond to Bregma -3.16 mm with reference
to Franklin and Paxinos (1997). Scale bar corresponding to high magnification, 250 mm, and low magnification, 25 mm.
doi:10.1371/journal.pone.0007027.g002
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spiny neurons projecting to the substantia nigra (direct pathway).
DRD1 and PDyn mRNA levels were significantly upregulated in
KO animals as compared to controls (Fig. 5A and B). In contrast
striatal mRNA expression levels for DRD2 and PPE did not differ
between control and mutant animals (Fig. 5A and B). As striatal
dynorphin positive neurons form connections with nigral DA
neurons, we investigated the effects of the mutation on nigral BDNF
mRNA levels. BDNF messenger levels were significantly increased
in Pten KO animals (Fig. 5C).
Extracellular DA Levels in Dorsal Striatum and correlation
to locomotor activity
As previous studies have suggested levels of enkephalin and
dynorphin are oppositely modulated by DA transmission, we next
investigated if DA levels in the striatum were altered by Pten
ablation in DA cells. We used the technique of in vivo microdialysis
to investigate the consequences of genetic deletion of Pten in DA
cells on basal extracellular DA dynamics as well as on potassium-
evoked DA release. Quantitative no net flux microdialysis revealed
no significant differences in basal dialysate levels (y-intercept) or in
the estimated extracellular concentration (x-intercept) of DA in the
dorsal striatum (Figure 6A). Moreover, the DA extraction fraction,
calculated as the slope of the no net flux regression line was
unchanged in KO mice, suggesting that deletion of Pten in DA
neurons did not alter the clearance of extracellular DA by the DA
transporter [26]. Conventional microdialysis revealed a marked
increase in basal dialysate DA levels in response to K
+ evoked
depolarization (Fig. 6C). No significant difference between control
and KO mice in KCl-evoked DA levels was observed in the dorsal
striatum (fig. 6C).
Mice lacking PTEN expression in DA cells showed an increase
in catecholamine content in both the midbrain containing the DA
cell bodies (fig. 6D) and in the terminal region in the dorsal
striatum (fig. 6B). This increase was specific for DA and its
metabolites since 5HT and 5HIAA levels were not altered (data
not presented). Consistent with the dialysis data, no changes were
observed in 3MT, a DA metabolite of primarily extracellular
origin. In accordance with striatal DA release levels, no differences
in locomotor activity were observed between control (n=11) and
Pten KO (n=15) animals during exposure to a novel environment
(Fig. 7).
Pten influences neuroprotection after a neurotoxic insult
A unilateral injection of 6OHDA into the striatum results in
progressive loss of DA neurons in the ventral mesencephalon, and
Figure 3. The lack of PTEN in DA neurons results in a significant enlargement of the ventral midbrain area, attributable to an
increase in the total number of DA neurons that are larger in size, and display more dendritic extensions. (A) The volume of the
substantia nigra compacta (SNc), ventral tegmental area (VTA) and substantia nigra reticulata (SNr) was significantly larger in Pten KO animals (n=4),
as compared to controls (n=4). The volume of all measured areas was at least 40% larger in KO animals, with the largest increment in size seen in the
SNr. (B) The increase in volume of the SNc and VTA from Pten KO animals was accompanied by a significant increase in the number of TH positive
neurons (B) and cell size (C) in both regions. (B) The mean number of TH positive profiles in Pten KO animals was 94016105.1 in the SNc, and
47756106.3 in the VTA, a 43% and 26% increase, respectively, when compared to controls. (C) The area of TH positive neurons was 47% and 39%
larger in the SNc and VTA of Pten KO animals as compared to controls. (D) The increase in the total volume covered by the SNr was attributable to an
increase in the number and caliber of TH-positive fibers present in Pten KO animals in parallel with an increase in the number and size of TH positive
cells in the SNc and VTA. All data are mean6SEM. *p,0.05, Student’s t-test.
doi:10.1371/journal.pone.0007027.g003
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PLoS ONE | www.plosone.org 7 September 2009 | Volume 4 | Issue 9 | e7027Figure 4. Pten KO animals do not show differences in striatal TH fiber density measurements. (A, C) Optical density values did not reveal
significant differences in striatal TH staining intensity between control (n=4) and Pten KO animals (n=4). (B) There were no significant differences in
area measurements corresponding to rostral and medial striatum. A slight but significant increase in area was observed in the caudal striatal region of
Pten KO animals as compared to controls. Scale bar, 500 mm. All data are mean6SEM. *p,0.05, Student’s t-test.
doi:10.1371/journal.pone.0007027.g004
Figure 5. Pten ablation in DA cells affect the direct striatal output system by significantly increasing mRNA expression levels for
DRD1 and pDyn in striatal medium spiny neurons. BDNF mRNA levels were significantly elevated in the ventral mesencephalon (A) Dopamie
receptor D1 (DRD1) and D2 (DRD2) mRNA expression levels in the striatum of control (n=9) and Pten KO animals (n=13). DRD1 mRNA expression
levels were significantly increased in KO animals as compared to controls. DRD2 mRNA levels were unchanged between the groups. (B) Changes in
DRD1 expression levels were accompanied by an elevation in prodynorphin (pDyn) mRNA in Pten KO animals. Preproenkephalin (PPE) mRNA
expression levels were unchanged. (C) BDNF mRNA levels were significantly increased in the ventral mesencephalon in KO animals. All data are
mean6SEM. *p,0.05, Student’s t-test.
doi:10.1371/journal.pone.0007027.g005
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striatae [30]. We found that Pten deletion protects DA neurons
during this partial 6OHDA lesion and prevents fiber loss in the
lesioned striatum when compared to control animals. Four weeks
after the lesion, control 6OHDA-treated mice showed an extensive
loss of TH positive SNc neurons in the ipsilateral or lesioned nigral
region (Fig. 8A and B). Stereologic cell counts in control animals
showed a 63% survival rate of TH positive neurons when
compared to the contralateral side. In contrast, Pten KO mice
showed an 89% survival rate on the lesioned side as compared to
the contralateral nigra (Fig. 8C). Pten deletion also provided
significant protection against axonal loss in the lesioned striatum.
Four weeks after the lesion, quantification of TH+ fiber density in
the lesioned striatum showed a significant decrease in optical
density levels in control animals when compared to Pten KO
animals. Significant differences in optical density were observed in
rostral, medial and caudal sections (Fig. 8D).
The morphological preservation of the dopaminergic system
observed in Pten KO animals was paralleled by a significant
decrease in behavioral impairment developed after this partial
6OHDA striatal lesion. Unilateral 6OHDA striatal lesions result in
an imbalance in the levels of DA between the two striatae. As DA
stores are depleted due to the loss of DA in axon terminals, the
injection of drugs that act to release DA, such as amphetamine,
will induce rotational behavior towards the denervated striatum.
We examined the effects of Pten deletion on amphetamine-induced
rotational asymmetry at different time points after 6OHDA
lesioning. Amphetamine-induced rotational activity was recorded
for 60 min following an injection of 2.5 mg/kg (+) methamphet-
amine HCl. The number of clockwise and counterclockwise turns
were counted and expressed as the number of net rotations to the
lesioned (ipsilateral) hemisphere (net rotations to ipsilateral
hemisphere = ipsilateral rotations – contralateral rotations). KO
animals exhibited a significant reduction in ipsilateral rotational
behavior when compared to control animals at 2 and 4 weeks after
the lesion (Fig. 9).
Discussion
Mice with targeted ablation of Pten in DA neurons provide a
unique opportunity to study the correlation between deregulated
PTEN signaling and specific changes in DA neurotransmission.
Figure 6. Selective Pten deletion in DA cells results in unaltered
extracellular dopamine dynamics in spite of a significant
increase in tissue catecholamine content. (A) Pten KO mice
showed no differences in basal extracellular dopamine as estimated by
the x-intercept in the no net flux analysis. DA clearance was also
unaltered as indicated by no change in the extraction fraction (slope of
the no net flux regression line). (C) Depolarization evoked dopamine
release was unaltered in Pten KO animals. The total tissue content of
dopamine (DA) was increased in the dorsal striatum (B) and the
midbrain (D) of Pten KO mice. Levels for the dopamine metablites
DOPAC (dihydroxyphenylacetic acid), and HVA (homovanillic acid) were
significantly inceased in the striatum and midbrain respectively. 3MT (3-
methoxytyramine) levels remained unchanged as compared to controls.
All data are mean6SEM. *p,0.05, Student’s t-test.
doi:10.1371/journal.pone.0007027.g006
Figure 7. Exposure to a novel environment does not enhance
locomotor activity in Pten KO mice. Control (n=11) and Pten KO
(n=15) animals were placed in activity chambers to measure the
locomotor response to a novel environment. No significant differences
were found in all parameters measured during a cummulative period of
30 minutes. Total distances traveled is shown as a representative
measure. All data are mean6SEM. *p,0.05, Student’s t-test.
doi:10.1371/journal.pone.0007027.g007
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inhibition of cell-survival promoting PI3K/Akt- dependent signals,
recent studies have shown PTEN regulates diverse functions in DA
neurons, and its relationship to Parkinson’s disease and drug
addiction has been highlighted. In this study, we have further
characterized PTEN function specific to postmitotic mouse
mesencephalic DA neurons. We generated a knockin mouse
expressing Cre recombinase under the transcriptional control of
Figure 8. Pten ablation shows neuroprotective effects in the intrastriatal 6OHDA mouse model. Animals were treated with a unilateral
6OHDA injection in the striatum, and perfused 4 weeks after the injection to analyze the effect of Pten ablation on the magnitude of the lesion. (A)
The SNc from control animals (n=4) was markedly affected by the lesion as reflected by the significant loss of TH positive profiles in the ipsilateral
side to the lesion as compared to the contralateral side. The dopaminergic neurons in Pten KO (n=6) animals were largely spared after the lesion
when compared to control animals. (B) The neuroprotective effects related to Pten ablation were observed at the level of the striatal axonal
projections as well. Depletion of TH positive terminals in the striatum was reduced across the striatum in control animals, while axon terminal
degeneration was much lower in Pten KO animals. (C) Survival rates for TH-positive neurons were quantified by stereologic counts. The number of
surviving neurons (presented as percent surviving neurons when compared to the side contralateral to the lesion) was significantly increased in Pten
KO animals (n=6) when compared to controls (n=4). (D) Optical density measurement in the injected striatum revealed a nearly complete
preservation of TH terminals in Pten KO animals. TH staining density was significantly lower in control 6OHDA-treated animals with the biggest
difference observed in the medial portion of the striatum, in accordance with sterotaxic coordinated used for the lesion. (A) Scale bar, 250 mm and (B)
500 mm. All data are mean6SEM. *p,0.05, Student’s t-test.
doi:10.1371/journal.pone.0007027.g008
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recombination events [15]. Pten was selectively deleted in DA
neurons in parallel to activation of the dopamine transporter at
embryonic day 15. In addition, to allow bicistronic mRNA
expression encoding for both DAT and Cre, we targeted the 39
untranslated region (39UTR) of the DAT gene where the Cre gene
is preceded by an internal ribosomal entry site (IRES). Pten KO
mice showed an enlarged ventral mesencephalon, neuronal
hypertophy and increased numbers of DA neurons. Despite the
robust trophic effects accompanied by a significant increase in
overall striatal DA tissue content, extracellular DA levels in the
striatum remained unchanged between control and Pten KO mice,
and potassium evoked DA release was not elevated in Pten KO
animals. However, DRD1 and PDyn mRNA levels were
significantly elevated in striatonigral projecting neurons. PTEN
inactivation protected DA neurons during exposure to a
neurotoxin. This initial study of PTEN deregulation selective to
DA neurons is aimed at describing the state of dopaminergic
transmission and molecular adaptations of the mesostriatal and
mesolimbic dopaminergic systems. The effects of PTEN deletion
in DA neurons, as well as postsynaptic regions will be discussed in
detail below.
Disruption of PTEN activity in DA neurons during
postmitotic developmental growth
Cell death by apoptosis is a normal developmental event
occurring in most neuronal populations, and it is a determinant of
the eventual size of a neuronal population. Developmental cell
death is often regulated by the trophic synaptic support that
neurons receive from their postsynaptic targets [31,32], as well as
from afferent projections [33]. Pruning of DA neurons in the
mouse ventral midbrain is essentially a postnatal event with the
number of apoptotic neurons culminating within the first days of
life [31]. A second peak of apoptotic death among dopaminergic
neurons occurs at postnatal day 14, a developmental period
corresponding to competition for synapse formation [34]. In
addition, and consistent with the model of target-derived support,
excitotoxic striatal lesions during development result in a reduced
number of nigro-striatal DA neurons. This decrease occurred in
spite of the axon-sparing nature of the lesion [35,36]. Thus, several
lines of evidence suggest trophic factors, synaptic interactions and
apoptotic events may play a key role in shaping the anatomy of the
ventral mesencephalon.
In this study, we have shown Pten deletion in differentiated DA
neurons causes a significant increase in the number and size of
surviving neurons in both the mesolimbic and nigrostriatal
projecting pathways. A known function of PTEN is antagonizing
cell survival signals mediated by Akt-dependent pathways. Akt, or
protein kinase B, exerts its role in promoting cell survival and
growth by targeting anti-apoptotic downstream signals [37,38].
Because at the time of Pten deletion DA neurons have already
completed mitosis and phenotypic determination, it is unlikely the
reported increase in DA neurons is due to an increase in newly
formed neurons. It is thus likely PTEN ablation preserves DA
neurons that normally would undergo apoptosis due to the lack of
target support, by repressing the initiation of apoptotic pathways.
While Pten deletion does not alter DA release, it induces
permanent changes in striatal postsynaptic markers
Ablation of PTEN in DA neurons did not only cause robust
anatomical changes in the ventral mesencephalon, but also
affected functional connections between DA neurons and target
areas. Interestingly, PTEN ablation did not generate changes in
TH optical density in the striatum or nucleus accumbens,
suggesting an equal distribution of dopaminergic terminals
between Pten KO and control animals. In vivo microdialysis studies
showed no differences in basal extracellular DA levels or in the
dynamics of neurotransmitter clearance in the dorsal striatum. In
addition potassium evoked depolarizations did not show an
increase in DA release in Pten KO animals when compared to
controls.
While no changes in DA release or uptake could be detected by
microdialysis, KO animals showed a significant increase in total
DA tissue content in dorsal striatum, an effect accompanied by a
significant increase in striatal prodynorphin and DRD1 mRNA
expression levels. As previous studies have shown enhancement of
DA neurotransmission often results in elevated dynorphin and
DRD1 mRNA levels in direct striatal projecting neurons, the
unbalance between the direct and indirect striatal projection
pathways observed in Pten KO animals could be explained by
subtle but long-term changes in DA dynamics. In addition, we
cannot rule out the possibility that the molecular changes
specifically observed in dynorphin positive medium spiny neurons
may be due to the direct synaptic interaction with DA neurons in
the ventral mesencephalon. Medium spiny neurons may depend
on trophic support and the availability of synaptic connections
with their target, the SN, to define their molecular profile or even
to survive during development. As Pten deletion creates a very
robust change in substantia nigra, it is possible that the nigra may
be in a better position to support afferent populations, such as the
medium spiny neurons. Increased BDNF mRNA levels in the
ventral mesencephalon in Pten KO animals, suggests that striatal
afferents may have increased availability to trophic support in KO
animals.
As locomotor activity and exposure to a novel environment are
closely associated with mesocortical and mesolimbic activity
[39,40], we compared the locomotor responses of control and
Pten KO animals when exposed to a novel environment.
Interestingly, and despite higher DA contents in the striatum,
Figure 9. The morphological preservation of the Pten deficient
nigrostriatal system after 6OHDA treatment correlates with
functional recovery after the lesion. To determine the functionality
of the nigrostriatal system after the lesion, we examined methamphet-
amine-induced rotations. Methamphetamine treatment increases the
extracellular availability of endogenous DA in the striatum, and it causes
animals with a partial DA depletion to rotate against the lesion side
(ipsilateral), due to the imbalance in DA release between the striatae.
Strong ipsilateral rotational behavior was observed in control animals
(n=8) after treatment with (+) methamphetamine HCl (2.5 mg/kg) at 14
and 28 days after the lesion. Ipsilateral rotational behavior was
significantly reduced in Pten KO animals (n=10). All data are mean6SEM.
*p,0.05, Student’s t-test.
doi:10.1371/journal.pone.0007027.g009
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exposed to a novel environment. Increased DRD1 and dynorphin
levels in medium spiny neurons may enhance the inhibition of DA
neurons in the SNc, thereby normalizing overall DA release in the
striatum.
Suppressing PTEN expression protects DA neurons
against exposure to a neurotoxin
The relationship between PTEN and Parkinson’s disease has
been emphasized in several studies often in reference to
mitochondrial function. PTEN downregulation in cultured
hippocampal neurons inhibits the release of cytochrome c during
toxic insults [41]. PTEN directly regulates the activity of PTEN-
induced putative kinase 1(PINK), a protein kinase that localizes to
mitochondria where it inhibits cytochrome c release, and known to
be mutated in certain forms of familial Parkinson’s disease [42]. In
addition, as an upstream modulator of Akt, the phosphatase
PTEN has been shown to play a role in the regulation of survival
signaling during neuronal injury. A previous study overexpressed a
constitutively active form of the oncoprotein Akt/PKB in neurons
of the ventral midbrain of adult mice using adeno-associated virus
transduction [12]. The authors reported a significant increase in
cell size and number of TH positive profiles in the SNc on the
injected side. In addition, TH immunostaining showed higher
density in the striatum ipsilateral to the adenoviral injection. There
was also near complete protection of DA neuron cell bodies after
intrastriatal 6OHDA lesion [12]. Our study provides further
evidence that ablating PTEN activity leads to decreased
dopaminergic neuronal death after a neurotoxic lesion. In
agreement with the above mention study, we showed that Pten
deletion specific to DA neurons confers significant protection
against 6OHDA mediated toxicity [43,44]. PTEN less DA
neurons displayed a significant increase in survival rate as
compared to control DA neurons. In addition, striatal TH density
levels were significantly elevated in Pten KO animals as compared
to controls. This data correlates with behavioral parameters, as
methamphetamine induced rotations were significantly decreased
in KO animals, suggesting increased maintenance of DA release in
the lesioned striatum.
The demonstration that PTEN/Akt mRNA expression is
modulated in response to different apoptotic inducers [7] strongly
suggests the association of this pathway with neuronal survival and
death. However, in recent years investigations have shown cellular
functions attributed to PTEN in various neuronal circuits go
beyond interactions with the Akt pathway, and have strengthened
the current view of this molecule as a potential therapeutic target.
For example, it has been recently shown that PTEN can physically
interact with serotonin receptors in dopamine neurons to
modulate transmission [45,46]. Such interactions were able to
affect the response of DA neurons to drugs of abuse, and therefore
manipulation of the PTEN pathway could potentially affect the
manner in which humans respond to reward and motivation. In
addition, PTEN activity has been related to mitochondrial
function in different neuronal systems, suggesting PTEN deregu-
lation may provide a dual neuroprotective function in dopamine
cells by the activation of survival pathways and maintenance of
mitochondrial function. This molecule may thus have activity not
only on cell death/survival, but also on other brain activities.
Further studies defining the function of PTEN in dopamine cells
may provide the molecular basis for the development of novel
therapeutic strategies to treat CNS diseases.
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